Altimmune Inc.

NASDAQ: ALT · Real-Time Price · USD
3.56
-0.07 (-1.93%)
At close: Aug 21, 2025, 11:26 AM

Altimmune Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
5K 5K 5K 5K 5K 5K 37K 362K 6K 21K -110K 2K 8K 32K 3.28M 157.56K 137.62K 837.52K
Cost of Revenue
30K n/a n/a 37K 61K 107K 1.89M 18.39M n/a -356K 110K 20.26M 15.99M 119K 21.05M 29.21M 13.27M 11M
Gross Profit
-25K 5K 5K 5K 5K -102K -1.85M -18.03M -13.25M 377K -220K -20.26M -15.98M -87K -17.77M -29.05M -13.13M -10.16M
Operating Income
-22.92M -21.82M -24.87M -24.77M -26.75M -26.79M -33.62M -22.54M -18.01M -21.76M -23.09M -24.75M -20.39M -19.5M -23.98M -33.2M -24.86M -14.86M
Interest Income
1.13M 1.54M 1.57M 1.91M 2.18M 2.41M 1.96M 1.88M 1.83M 1.67M 1.65M 1.05M 328K 21K 176K 13K 33K 42K
Pretax Income
-22.15M -20.26M -23.18M -22.84M -24.64M -24.39M -31.64M -20.67M -16.06M -20.07M -21.66M -23.71M -20.11M -19.43M -23.89M -33.51M -24.83M -14.86M
Net Income
-22.15M -19.57M -23.18M -22.84M -24.64M -24.39M -31.64M -20.67M -16.06M -18.39M -20.23M -23.52M -20.11M -19.36M -23.89M -33.51M -24.83M -14.86M
Selling & General & Admin
5.69M 5.99M 5.09M 4.97M 5.59M 5.31M 4.33M 4.51M 4.76M 4.53M 3.81M 4.49M 4.41M 4.43M 3.78M 4.16M 3.66M 3.82M
Research & Development
17.24M 15.83M 19.78M 19.8M 21.16M 21.49M 16.91M 18.39M 13.25M 17.25M 19.18M 20.26M 15.99M 15.1M 20.19M 29.21M 13.27M 11.88M
Other Expenses
n/a n/a n/a n/a n/a -107K -1.89M n/a n/a 19K -217K 50K 25K 110K -80.64K -286.2K 26.1K -33.13K
Operating Expenses
22.93M 21.82M 24.87M 24.77M 26.75M 26.69M 19.35M 22.9M 18.01M 21.78M 22.98M 24.75M 20.4M 19.53M 23.96M 33.36M 16.93M 15.7M
Interest Expense
264K 1K 1K 6K 1K 1K 2K 29K 2K 2K n/a 64K 65K 62K n/a 33K 22K 12K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
22.93M 21.82M 24.87M 24.77M 26.75M 26.8M 33.66M 22.9M 18.01M 21.78M 22.98M 24.75M 20.4M 19.53M 23.96M 33.36M 16.93M 15.7M
Income Tax Expense
n/a -681K n/a n/a n/a n/a n/a n/a n/a -1.68M -1.43M -197K 90K -69K n/a -253.33K 48.32K -21.46K
Shares Outstanding (Basic)
81.48M 75.55M 71.26M 71.08M 70.92M 70.8M 58.25M 53.63M 50.69M 50.13M 50.03M 48.99M 47.5M 43.97M 41.71M 41.37M 41.36M 38.91M
Shares Outstanding (Diluted)
81.48M 75.55M 71.26M 71.08M 70.92M 70.8M 58.44M 53.63M 50.69M 50.13M 50.03M 49.29M 47.5M 43.97M 41.71M 41.37M 41.36M 38.91M
EPS (Basic)
-0.27 -0.26 -0.33 -0.32 -0.35 -0.34 -0.54 -0.39 -0.32 -0.37 -0.4 -0.48 -0.42 -0.44 -0.57 -0.81 -0.6 -0.38
EPS (Diluted)
-0.27 -0.26 -0.33 -0.32 -0.35 -0.34 -0.54 -0.39 -0.32 -0.37 -0.4 -0.48 -0.42 -0.44 -0.57 -0.81 -0.6 -0.38
EBITDA
-22.92M -20.23M -23.15M -22.8M -24.58M -24.29M -29.75M -20.52M -16.06M -20.43M -23.09M -23.65M -19.99M -19.25M -23.56M -33.37M -24.73M -14.78M
EBIT
-21.88M -20.25M -23.18M -22.84M -24.64M -24.39M -31.64M -20.64M -16.06M -20.07M -21.84M -23.65M -20.04M -19.37M -23.95M -33.48M -24.8M -14.85M
Depreciation & Amortization
30K 29K 33K 37K 61K 107K 1.89M 117K 121K -356K -236K -141K 53K 119K 331.38K 106.64K 75.09K 74.3K